Safety And Efficacy Of Bosutinib
NCT02501330
·
clinicaltrials.gov ↗
COMPLETED
Status
702
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Myelogenous Leukemia
Interventions
DRUG:
Bosutinib
Sponsor
Pfizer